Evidence map›Paper›PMID 25355890›Full record

ArticleJournal of virology2015

Discovery and characterization of auxiliary proteins encoded by type 3 simian T-cell lymphotropic viruses.

Jocelyn Turpin, Chloé Journo, Nga Ling Ko, Flore Sinet, Alexandre Carpentier, Amandine Galioot, Dustin Edwards, Anne-Mieke Vandamme, Louis Gazzolo, Madeleine Duc Dodon and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 4 countries.

Jocelyn TurpinEquipe Oncogenèse Rétrovirale, Lyon, France Equipe Labellisée Ligue Nationale Contre le Cancer, Lyon, France International Center for Research in Infectiology, INSERM U1111-CNRS UMR5308, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Lyon, France.
Chloé JournoEquipe Oncogenèse Rétrovirale, Lyon, France Equipe Labellisée Ligue Nationale Contre le Cancer, Lyon, France International Center for Research in Infectiology, INSERM U1111-CNRS UMR5308, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Lyon, France.
Nga Ling KoEpidémiologie et Physiopathologie des Virus Oncogènes, CNRS UMR 3569, Pasteur Institute, Paris, France.
Flore SinetEquipe Oncogenèse Rétrovirale, Lyon, France Equipe Labellisée Ligue Nationale Contre le Cancer, Lyon, France International Center for Research in Infectiology, INSERM U1111-CNRS UMR5308, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Lyon, France Master Biosciences ENS Lyon, Lyon, France.
Alexandre CarpentierMolecular and Cellular Epigenetics (GIGA) and Molecular Biology (Gembloux Agro-Bio Tech), University of Liège, Liège, Belgium.
Amandine GaliootEquipe Oncogenèse Rétrovirale, Lyon, France Equipe Labellisée Ligue Nationale Contre le Cancer, Lyon, France International Center for Research in Infectiology, INSERM U1111-CNRS UMR5308, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Lyon, France Master Biosciences ENS Lyon, Lyon, France.
Dustin EdwardsVirus Tumor Biology Section, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Anne-Mieke VandammeUniversity of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Leuven, Belgium, and Centro de Malária e outras Doenças Tropicais and Unidade de Microbiologia, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.
Louis GazzoloEcole Normale Supérieure de Lyon, Lyon, France Laboratoire de Biologie Moléculaire de la Cellule, Unité Mixte de Recherche 5239, Centre National de la Recherche Scientifique, UMS3444 Biosciences Lyon-Gerland, Lyon, France.
Madeleine Duc DodonEcole Normale Supérieure de Lyon, Lyon, France Laboratoire de Biologie Moléculaire de la Cellule, Unité Mixte de Recherche 5239, Centre National de la Recherche Scientifique, UMS3444 Biosciences Lyon-Gerland, Lyon, France.
Antoine GessainEpidémiologie et Physiopathologie des Virus Oncogènes, CNRS UMR 3569, Pasteur Institute, Paris, France.
Fatah KashanchiNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, USA.
Ivan BalansardUMS 3537 CNRS-AMU, Marseille, France.
Romain LacosteStation de Primatologie-UPS846-CNRS, Rousset sur Arc, France.
Renaud MahieuxEquipe Oncogenèse Rétrovirale, Lyon, France Equipe Labellisée Ligue Nationale Contre le Cancer, Lyon, France International Center for Research in Infectiology, INSERM U1111-CNRS UMR5308, Lyon, France Ecole Normale Supérieure de Lyon, Lyon, France Université Lyon 1, Lyon, France renaud.mahieux@ens-lyon.fr.
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FRÉcole Normale Supérieure de Lyon · FRGeorge Mason University · USNational Cancer Institute · USRega Institute for Medical Research · BEUniversity of Liège · BE

Funding

Mechanism of activated transcription in the new HTLV-3 virusR21AI072495 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2007 to 2008
$424k
NIAID NIH HHS AI072495-01NIAID NIH HHS R21 AI072495
6 · The paper itself

Abstract

unlabelledHuman T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 encode auxiliary proteins that play important roles in viral replication, viral latency, and immune escape. The presence of auxiliary protein-encoding open reading frames (ORFs) in HTLV-3, the latest HTLV to be discovered, is unknown. Simian T-cell lymphotropic virus type 3 (STLV-3) is almost identical to HTLV-3. Given the lack of HTLV-3-infected cell lines, we took advantage of STLV-3-infected cells and of an STLV-3 molecular clone to search for the presence of auxiliary transcripts. Using reverse transcriptase PCR (RT-PCR), we first uncovered the presence of three unknown viral mRNAs encoding putative proteins of 5, 8, and 9 kDa and confirmed the presence of the previously reported RorfII transcript. The existence of these viral mRNAs was confirmed by using splice site-specific RT-PCR with ex vivo samples. We showed that p5 is distributed throughout the cell and does not colocalize with a specific organelle. The p9 localization is similar to that of HTLV-1 p12 and induced a strong decrease in the calreticulin signal, similarly to HTLV-1 p12. Although p8, RorfII, and Rex-3 share an N-terminal sequence that is predicted to contain a nucleolar localization signal (NoLS), only p8 is found in the nucleolus. The p8 location in the nucleolus is linked to a bipartite NoLS. p8 and, to a lesser extent, p9 repressed viral expression but did not alter Rex-3-dependent mRNA export. Using a transformation assay, we finally showed that none of the STLV-3 auxiliary proteins had the ability to induce colony formation, while both Tax-3 and antisense protein of HTLV-3 (APH-3) promoted cellular transformation. Altogether, these results complete the characterization of the newly described primate T-lymphotropic virus type 3 (PTLV-3). IMPORTANCE: Together with their simian counterparts, HTLVs form the primate T-lymphotropic viruses. HTLVs arose from interspecies transmission between nonhuman primates and humans. HTLV-1 and HTLV-2 encode auxiliary proteins that play important roles in viral replication, viral latency, and immune escape. The presence of ORFs encoding auxiliary proteins in HTLV-3 or STLV-3 genomes was unknown. Using in silico analyses, ex vivo samples, or in vitro experiments, we have uncovered the presence of 3 previously unknown viral mRNAs encoding putative proteins and confirmed the presence of a previously reported viral transcript. We characterized the intracellular localization of the four proteins. We showed that two of these proteins repress viral expression but that none of them have the ability to induce colony formation. However, both Tax and the antisense protein APH-3 promote cell transformation. Our results allowed us to characterize 4 new retroviral proteins for the first time.

Indexed as

Gene Expression ProfilingAnimalsCell LineCell NucleusCytosolHumansMolecular WeightReverse Transcriptase Polymerase Chain ReactionSimian T-lymphotropic virus 3Viral ProteinsViral Proteins

Identifiers

PMID25355890
PMCPMC4300634
OpenAlexW2004674426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.